DACS
MRNA icon

Dymon Asia Capital (Singapore)’s Moderna MRNA Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,000
Closed -$4.29M – 129
2022
Q2 		$4.29M Hold
30,000
– – 0.31% 33
2022
Q1 		$5.17M Buy
+30,000
New +$5.05M 0.36% 40
2021
Q3 		– Sell
-15,000
Closed -$3.52M – 127
2021
Q2 		$3.52M Hold
15,000
– – 0.37% 44
2021
Q1 		$1.96M Buy
+15,000
New +$2.17M 0.14% 64

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s MRNA Position: Q3 2022 in Review

Dymon Asia Capital (Singapore) sold out of Moderna (MRNA) in Q3 2022, closing a stake of 12,131 shares — an estimated $1.73M sold.

Dymon Asia Capital (Singapore) first reported a position in MRNA in Q1 2021 and held it in 3 quarters. The position peaked at $1.73M in Q2 2022. 916 funds tracked by Wall St. Rank hold MRNA as of Q3 2022.

  • Dymon Asia Capital (Singapore) reported no remaining Moderna position as of Q3 2022 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 12,131 Moderna shares in Q3 2022, an estimated $1.73M.
  • Dymon Asia Capital (Singapore) first reported a position in Moderna in Q1 2021 and held it in 3 quarters.
  • Dymon Asia Capital (Singapore)'s Moderna position peaked at $1.73M in Q2 2022.
  • 916 funds tracked by Wall St. Rank held Moderna as of Q3 2022.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q3 2022, filed 14 Nov 2022.